NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Breast cancer (early) - paclitaxel - NICE TAG TA108

Breast cancer (early) - paclitaxel - NICE TAG TA108

This guidance replaces paragraph 1.3 of Taxanes for the treatment of breast cancer (NICE technology appraisal guidance 30) issued in September 2001 [Replaced by NICE clinical guideline 81].

CG80 Early and locally advanced breast cancer updates the recommendations contained in this appraisal.

For details, see 'About this guidance'.

1.1 Paclitaxel, within its licensed indication, is not recommended for the adjuvant treatment of women with early node-positive breast cancer.


Site by Devopa
© Copyright 2022 NHS. All rights reserved.